Si-Bone (SIBN) Preferred Stock Liabilities (2017 - 2018)
Si-Bone's quarterly Preferred Stock Liabilities came in at $118.5 million in Q3 2018, little changed quarter-over-quarter from $118.5 million in Q4 2017.
Si-Bone has reported Preferred Stock Liabilities for 2 years, with the latest figure at $118.5 million in Q3 2018.
- For the quarter ending Q3 2018, Preferred Stock Liabilities changed N/A year-over-year to $118.5 million; the trailing twelve-month figure through Sep 2018 stood at $118.5 million (changed N/A YoY), and the FY2017 full-year result was $118.5 million, changed N/A from the prior year.
- Preferred Stock Liabilities for Q3 2018 stood at $118.5 million, roughly flat from $118.5 million in the prior quarter.
- The five-year high for Preferred Stock Liabilities was $118.5 million in Q4 2017, with the low at $118.5 million in Q4 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Si-Bone | 611.92 Mn | 471.80 Mn | 41.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 118.55 Mn |
| Dec 31, 2017 | 118.55 Mn |